ARMISTICE CAPITAL LLC 13D and 13G filings for Verrica Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 9:39 pm Sale | 2025-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | ARMISTICE CAPITAL LLC | 439,657 4.990% | -199,536 (-31.22%) | Filing |
| 2025-11-14 6:29 pm Purchase | 2025-09-30 | 13G | Verrica Pharmaceuticals Inc. VRCA | ARMISTICE CAPITAL LLC | 639,193 6.770% | 639,193 (New Position) | Filing |